Wechsler Memory Scale, Rivermead Behavioral Memory Test, and Everyday Memory Questionnaire in Healthy Adults and Alzheimer Patients

2002 ◽  
Vol 18 (1) ◽  
pp. 63-77 ◽  
Author(s):  
Anastasia Efklides ◽  
Efterpi Yiultsi ◽  
Theopisti Kangellidou ◽  
Fotini Kounti ◽  
Fotini Dina ◽  
...  

Summary: The Wechsler Memory Scale (WMS) is a laboratory-based memory test that has been criticized for its lack of ecological validity and for not testing long-term memory. A more recent memory test, which aims at testing everyday memory, is the Rivermead Behavioral Memory Test (RBMT); it tests prospective memory and other forms of memory not tapped by WMS. However, even this test does not capture all aspects of everyday memory problems often reported by adults. These problems are the object of the Everyday Memory Questionnaire (EMQ). This study aimed at identifying the relationships between these three memory tests. The differential effect of Alzheimer's disease (AD) on the above relationships was also studied. The sample consisted of 233 healthy adults (20 to 75+ years of age) and 39 AD patients (50 to 75 years of age). Confirmatory factor analysis revealed the following latent factors: Verbal Memory, Visual Reconstruction, Orientation, Message (action embedded in spatial context), Visual Recognition, Spatial Memory, New Learning/Association Forming, Prospective/Episodic Memory, and Metamemory. These first-order factors were further explained by two second-order factors: Semantic Memory and Coordination of Semantic and Visuo-Spatial Memory. This basic structure was preserved in the sample of AD patients, although AD patients performed less well on the WMS and the RBMT. Some interesting findings regarding semantic memory, face recognition, and metamemory in AD patients are also reported. Age, education, but no gender effects on memory performance were also detected.

2017 ◽  
Vol 9 (3) ◽  
pp. 405
Author(s):  
Inés Casado Verdejo ◽  
Carmen Bárcena Calvo

RESUMENEl objetivo de este trabajo fue validar y conocer las propiedades psicométricas del Cuestionario de Memoria Cotidiana (CMC) inspirado en el Everyday Memory Questionnaire (EMQ) de Baddeley (1997). Se comprobó su fiabilidad y la validez de constructo y se determinaron sus dimensiones a través de su análisis factorial. En un primer momento participaron 129 adultos sin patología cognitiva, de edades comprendidas entre los 48 y los 91 años de edad. En un segundo momento, con una muestra de 510 adultos sanos de edades comprendidas entre los 48 y los 90 años, se quiso saber si existe afectación diferenciada de las distintas dimensiones de memoria cotidiana establecidas. Los resultados permiten concluir que dicha medida pluridimensional posee propiedades psicométricas adecuadas, alfa de Cronbach de .91, y se evidencia que existen sistemas o áreas componentes de la memoria cotidiana diferencialmente resistentes al deterioro. Los fallos cognitivos autoinformados indican que las áreas que más deterioro sufren con el paso de los años son el recuerdo del sitio de las cosas y la memoria de fuente, siendo la más resistente la memoria autobiográfica en ambos sexos.ABSTRACTThe main of this work was to validate and to know the psychometric properties of the Cuestionario de Memoria Cotidiana (CMC) inspired in Baddeley's Everyday Memory Questionnaire (EMQ) (1997). We checked their reliability and construct validity and their dimensions were determined through their factorial analysis. We make, at first, with a sample of 129 adults not suffering from any cognitive pathology and aged between 48 and 91 years. And at a later stage, a sample of 510 healthy adults with ages ranging from 48 and 90 years was used to discover if there were any differentiation of effects in the various dimensions of everyday memory that were established. Results shown that this multi-dimensional measurement has acceptable psychometric properties, with a Cronbach’s alpha of 0.91, and also provided evidence that there are systems or areas making up every-day memory that are differentially resistant to deterioration. Self-reported cognitive failures indicated that the areas suffering most downgrading with the passage of time are recall of the location of objects and source memory, with autobiographic memory being more resistant in both sexes.


2011 ◽  
Author(s):  
Alan Sunderland ◽  
John E. Harris ◽  
Alan D. Baddeley

2020 ◽  
Vol 24 (4) ◽  
pp. 1-182 ◽  
Author(s):  
Nadina B Lincoln ◽  
Lucy E Bradshaw ◽  
Cris S Constantinescu ◽  
Florence Day ◽  
Avril ER Drummond ◽  
...  

Background People with multiple sclerosis have problems with memory and attention. The effectiveness of cognitive rehabilitation has not been established. Objectives The objectives were to assess the clinical effectiveness and cost-effectiveness of a cognitive rehabilitation programme for people with multiple sclerosis. Design This was a multicentre, randomised controlled trial in which participants were randomised in a ratio of 6 : 5 to receive cognitive rehabilitation plus usual care or usual care alone. Participants were assessed at 6 and 12 months after randomisation. Setting The trial was set in hospital neurology clinics and community services. Participants Participants were people with multiple sclerosis who had cognitive problems, were aged 18–69 years, could travel to attend group sessions and gave informed consent. Intervention The intervention was a group cognitive rehabilitation programme delivered weekly by an assistant psychologist to between four and six participants for 10 weeks. Main outcome measures The primary outcome was the Multiple Sclerosis Impact Scale – Psychological subscale at 12 months. Secondary outcomes included results from the Everyday Memory Questionnaire, the 30-Item General Health Questionnaire, the EuroQol-5 Dimensions, five-level version and a service use questionnaire from participants, and the Everyday Memory Questionnaire – relative version and the Modified Carer Strain Index from a relative or friend of the participant. Results Of the 449 participants randomised, 245 were allocated to cognitive rehabilitation (intervention group) and 204 were allocated to usual care (control group). Of these, 214 in the intervention group and 173 in the control group were included in the primary analysis. There was no clinically important difference in the Multiple Sclerosis Impact Scale – Psychological subscale score between the two groups at the 12-month follow-up (adjusted difference in means –0.6, 95% confidence interval –1.5 to 0.3; p = 0.20). There were no important differences between the groups in relation to cognitive abilities, fatigue, employment, or carer strain at follow-up. However, there were differences, although small, between the groups in the Multiple Sclerosis Impact Scale – Psychological subscale score at 6 months (adjusted difference in means –0.9, 95% confidence interval –1.7 to –0.1; p = 0.03) and in everyday memory on the Everyday Memory Questionnaire as reported by participants at 6 (adjusted difference in means –5.3, 95% confidence interval –8.7 to –1.9) and 12 months (adjusted difference in means –4.4, 95% confidence interval –7.8 to –0.9) and by relatives at 6 (adjusted difference in means –5.4, 95% confidence interval –9.1 to –1.7) and 12 months (adjusted difference in means –5.5, 95% confidence interval –9.6 to –1.5) in favour of the cognitive rehabilitation group. There were also differences in mood on the 30-Item General Health Questionnaire at 6 (adjusted difference in means –3.4, 95% confidence interval –5.9 to –0.8) and 12 months (adjusted difference in means –3.4, 95% confidence interval –6.2 to –0.6) in favour of the cognitive rehabilitation group. A qualitative analysis indicated perceived benefits of the intervention. There was no evidence of a difference in costs (adjusted difference in means –£574.93, 95% confidence interval –£1878.93 to £729.07) or quality-adjusted life-year gain (adjusted difference in means 0.00, 95% confidence interval –0.02 to 0.02). No safety concerns were raised and no deaths were reported. Limitations The trial included a sample of participants who had relatively severe cognitive problems in daily life. The trial was not powered to perform subgroup analyses. Participants could not be blinded to treatment allocation. Conclusions This cognitive rehabilitation programme had no long-term benefits on quality of life for people with multiple sclerosis. Future work Future research should evaluate the selection of those who may benefit from cognitive rehabilitation. Trial registration Current Controlled Trials ISRCTN09697576. Funding This project was funded by the National Institute for Health Research Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 4. See the National Institute for Health Research Journals Library website for further project information.


Assessment ◽  
1996 ◽  
Vol 3 (4) ◽  
pp. 443-448 ◽  
Author(s):  
Deborah C. Koltai ◽  
Rosemarie M. Bowler ◽  
Rosemarie M. Bowler

Investigations questioning the ecological validity of standardized neuropsychological instruments have led to the development of tests that are purported to be relevant to everyday functioning. The present investigation examined the relationships of the Rivermead Behavioural Memory Test (RBMT) and the Wechsler Memory Scale-Revised (WMS-R) to estimates of everyday memory functioning, as measured by patient and relative ratings on the Everyday Memory Questionnaire (EMQ). The research participants consisted of a group allegedly exposed to neurotoxicants (n = 29), and a demographically similar comparison group ( n = 20). Results indicated that the two objective memory tests did not significantly differ in their relationships to estimates of everyday memory functioning, and that use of the tests together did not improve prediction of memory complaints over the use of one test alone. In addition, patient and relative ratings were highly correlated. These results are discussed within the context of the validity of patient and relative rating scales as estimates of everyday memory impairment.


2004 ◽  
Vol 10 (2) ◽  
pp. 67-75 ◽  
Author(s):  
Karen Drysdale ◽  
Arthur Shores ◽  
Wayne Levick

2021 ◽  
Vol 11 (5) ◽  
pp. 551
Author(s):  
Yingying Yang ◽  
Zachary M. Himmelberger ◽  
Trent Robinson ◽  
Megan Davis ◽  
Frances Conners ◽  
...  

Although memory functions in people with Down Syndrome (DS) have been studied extensively, how well people with DS remember things about everyday life is not well understood. In the current study, 31 adolescents/young adults with DS and 26 with intellectual disabilities (ID) of mixed etiology (not DS) participated. They completed an everyday memory questionnaire about personal facts and recent events (e.g., school name, breakfast). They also completed a standard laboratory task of verbal long-term memory (LTM) where they recalled a list of unrelated words over trials. Results did not indicate impaired everyday memory, but impaired verbal LTM, in people with DS relative to people with mixed ID. Furthermore, the laboratory verbal LTM task predicted everyday memory for both groups after taking into account mental age equivalent. Our research showed both an independence and a connection between everyday memory and the standard laboratory memory task and has important research and clinical implications.


Sign in / Sign up

Export Citation Format

Share Document